Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The biology and clinical potential of circulating tumor cells.
Lozar T, Gersak K, Cemazar M, Kuhar CG, Jesenko T. Lozar T, et al. Among authors: kuhar cg. Radiol Oncol. 2024 Sep 15;58(3):458. doi: 10.2478/raon-2024-0055. eCollection 2024 Sep 1. Radiol Oncol. 2024. PMID: 39287172 Free PMC article. No abstract available.
The biology and clinical potential of circulating tumor cells.
Lozar T, Gersak K, Cemazar M, Kuhar CG, Jesenko T. Lozar T, et al. Among authors: kuhar cg. Radiol Oncol. 2019 May 8;53(2):131-147. doi: 10.2478/raon-2019-0024. Radiol Oncol. 2019. PMID: 31104002 Free PMC article. Review.
Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth.
Kamposioras K, Mauri D, Papadimitriou K, Anthoney A, Hindi N, Petricevic B, Dambrosio M, Valachis A, Kountourakis P, Kopecky J, Kuhar CG, Popovic L, Chilingirova NP, Zarkavelis G, de Mello RA, Plavetić ND, Christopoulos C, Mostert B, Goffin JR, Tzachanis D, Saraireh HH, Ma F, Pavese I, Tolia M. Kamposioras K, et al. Among authors: kuhar cg. Front Oncol. 2020 Nov 19;10:575148. doi: 10.3389/fonc.2020.575148. eCollection 2020. Front Oncol. 2020. PMID: 33330049 Free PMC article. Review.
Efficacy and safety of selective cyclin-dependent kinases 4/6 inhibitors in hormone-receptor-positive, HER2-negative advanced breast cancer - results from a real-world setting.
KovaČ A, Matos E, Kuhar CG, Čakš M, Ovčariček T, Mencinger M, Humar M, Borštnar S. KovaČ A, et al. Among authors: kuhar cg. Cancer Treat Res Commun. 2020;25:100201. doi: 10.1016/j.ctarc.2020.100201. Epub 2020 Aug 27. Cancer Treat Res Commun. 2020. PMID: 32979704 Free article.
18 results